Sort
261,768 grants matching “gene therapy”
Development of strategies to achieve immunoprotection against Cryptosporidiosis
$1,012,009Saul R Tzipori · University Of Maryland Baltimore · U19 · FY2016 · AI
A Rational Systematic Approach to Find Combinations of Pharmacologic and Immune Therapies that Target Identifiable Oncogenic States
$1,011,983Pablo Tamayo · University Of California, San Diego · U01 · FY2017 · CA
Hsp70 and Hsp90 chaperones
$1,011,975Daniel Masison · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2025 · DK
PTEN and Cancer
$1,011,974Ramon E Parsons · Icahn School Of Medicine At Mount Sinai · R35 · FY2021 · CA
PTEN and Cancer
$1,011,974Ramon E Parsons · Icahn School Of Medicine At Mount Sinai · R35 · FY2020 · CA
Red Cell Biology
$1,011,971David M. Bodine · National Human Genome Research Institute · ZIA · FY2021 · HG
Sphingolipid Biology of Neurodegeneration
$1,011,947Richard Proia · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2022 · DK
Structural and Functional Characterization of Allergens
$1,011,885Robert E London · National Institute Of Environmental Health Sciences · ZIA · FY2016 · ES
National Gene Vector Biorespository and Coordinating Center at Indiana University
$1,011,840Kenneth G Cornetta · Indiana University Indianapolis · P40 · FY2009 · RR
Novel Therapies for Alcoholic Hepatitis
$1,011,775Arthur J McCullough · Cleveland Clinic Lerner Com-Cwru · U01 · FY2013 · AA
Determining the Fate of Transmembrane Proteins
$1,011,521Allan M Weissman · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Enabling use of blood spot cards for accurate high throughput Fragile X screening
$1,011,519Gary J Latham · Asuragen, Inc. · R44 · FY2014 · HD
Therapy for NF1-Related Tumors and other Genetic Tumor Predisposition Syndromes
$1,011,508Brigitte Widemann · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Correlates and Consequences of Increased Immune Activation in HIV + and - IDUs
$1,011,463Martin H Markowitz · Aaron Diamond Aids Research Center · R01 · FY2012 · DA
Role of 11q23 Chromosome Abnormalities in the Causation of Acute Leukemia
$1,011,385Carlo M Croce · Ohio State University · P01 · FY2009 · CA
Discovering mechanisms of neuroblastoma tumorigenesis to improve patient outcomes
$1,011,360John M Maris · Children'S Hosp Of Philadelphia · R35 · FY2022 · CA
International Tuberculosis Clinical Research
$1,011,326Clifton Barry · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
Neuronal and Progenitor/Stem Cell Function During Salivary Gland Development
$1,010,958Matthew Hoffman · National Institute Of Dental & Craniofacial Research · ZIA · FY2014 · DE
Genetic Analysis of the Multidrug Resistance Phenotype in Tumor Cells
$1,010,861Michael M Gottesman · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
CELL THERAPY CORE
$1,010,803Michael I Nishimura · Loyola University Chicago · P01 · FY2013 · CA
Role of inflammation, innate resistance, and immunity in carcinogenesis
$1,010,680Giorgio Trinchieri · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
MODEL SYSTEMS TOWARD DEVELOPMENT OF HUMAN GENE THERAPY
$1,010,583University Of Pittsburgh At Pittsburgh · P01 · FY2002 · DK
Center for Fetal Gene Transfer for Heart, Lung, and Blood Diseases
$1,010,546Alice F Tarantal · University Of California At Davis · R24 · FY2014 · HL
Human Cell Assay Core
$1,010,521David M Gamm · University Of Wisconsin-Madison · U19 · FY2024 · NS
Human Cell Assay Core
$1,010,521David M Gamm · University Of Wisconsin-Madison · U19 · FY2025 · NS